Abstract
Many lipoproteins are expressed on the surfaces of mycoplasmas, and some have been implicated as playing roles in pathogenesis. Family 2 lipoproteins ofMycoplasma pneumoniaehave a conserved “mycoplasma lipoprotein X” central domain and a “mycoplasma lipoprotein 10” C-terminal domain and are differentially expressed in response to environmental conditions. Homologues of family 2 lipoproteins areMycoplasmaspecific and include the lipoprotein ofMycoplasma gallisepticum, encoded by the MGA0674 gene. Comparative transcriptomic analysis of theM. gallisepticumlive attenuated vaccine strain F and the virulent strain Rlow, reported in this study, indicated that MGA0674 is one of several differentially expressed genes. The MGA0674-encoded lipoprotein is a proteolytically processed, immunogenic, TX-114 detergent-phase protein which appears to have antigenic divergence between field strains Rlowand S6. We examined the virulence of an RlowΔMGA0674 mutant (P1H9)in vivoand observed reduced recovery and attenuated virulence in the tracheas of experimentally infected chickens. The virulence of two additional RlowΔMGA0674 mutants, 2162 and 2204, was assessed in a secondin vivovirulence experiment. These mutants exhibited partial to complete attenuationin vivo, but recovery was observed more frequently. Since onlyMycoplasmaspecies harbor homologues of MGA0674, the gene product has been renamed “Mycoplasma-specific lipoprotein A” (MslA). Collectively, these data indicate that MslA is an immunogenic lipoprotein exhibiting reduced expression in an attenuated strain and plays a role inM. gallisepticumvirulence.

This publication has 38 references indexed in Scilit: